(Q28275566)

1

object named as

Michael G Hennerici

0 references

author name string

Richard Kay

2

0 references

Gian Luigi Lenzi

4

0 references

Marc Verstraete

5

0 references

Jean Marc Orgogozo

Tissue plasminogen activator for acute ischemic stroke

6

0 references

language of work or name

English

0 references

publication date

25 November 2006

0 references

published in

The Lancet

0 references

volume

368

0 references

issue

9550

0 references

page(s)

1871-8

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969776-6

7 January 2021

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969776-6

7 January 2021

Therapeutic defibrination in the treatment of thrombotic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969776-6

7 January 2021

Prolonged coagulation defect (defibrination syndrome) in Malayan viper bite

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969776-6

7 January 2021

Ancrod causes rapid thrombolysis in patients with acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969776-6

7 January 2021

Controlled trial of ancrod and heparin in treatment of deep-vein thrombosis of lower limb

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969776-6

7 January 2021

Controlled Defibrination in the Treatment of Peripheral Vascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969776-6

7 January 2021

Central retinal vein thrombosis: serial treatment with defibrination, aspirin and plasminotropic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969776-6

7 January 2021

Controlled Trial of Ancrod in Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969776-6

7 January 2021

Use of ancrod in acute or progressing ischemic cerebral infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969776-6

7 January 2021

Ancrod for the treatment of acute ischemic brain infarction. The Ancrod Stroke Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969776-6

7 January 2021

Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969776-6

7 January 2021

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969776-6

7 January 2021

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969776-6

7 January 2021

Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cumulative meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969776-6

7 January 2021

Acute stroke: usefulness of early CT findings before thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969776-6

7 January 2021

Multicenter trial of hemodilution in ischemic stroke--background and study protocol. Scandinavian Stroke Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969776-6

7 January 2021

Formal approaches to safety monitoring of clinical trials in life-threatening conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969776-6

7 January 2021

Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969776-6

7 January 2021

The B-Value: A Tool for Monitoring Data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969776-6

7 January 2021

Statin drugs and the risk of fracture

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969776-6

7 January 2021

The Desmoteplase in Acute Ischemic Stroke Trial (DIAS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969776-6

7 January 2021